SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences informs about disclosure

06 May 2023 Evaluate
Pursuant to Circular No SEBI/HO/DDHS CIR/P/2018/144 dated 26th November, 2018 and LIST/COMP/05/2019-20 dated 11th April, 2019 issued by SEBI on Fund raising by issuance of Debt Securities by Large Entities, Kimia Biosciences has confirmed that the company, Kimia Biosciences does not fall under the category of Large Corporate (LC) as per the framework provided under clause 2.2 of the said Circular. Hence, the Company is not required to submit any disclosure to the Stock Exchange.

The above information is a part of company’s filings submitted to BSE.

Kimia Biosciences Share Price

37.97 0.29 (0.77%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×